Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of single and repeat doses of RV1729 in individuals with asthma and in healthy volunte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RV1729

Snippet

Sponsor: Respivert Ltd | Conditions: Asthma, Healthy Volunteers | Phase 1 | Status: COMPLETED